health professionals, and scientists who treat or research those with or at risk for arthritis and rheumatic and musculoskeletal diseases. The annual meeting is the leading forum for you to find the most relevant and cutting-edge rheumatology information. ...
health professionals, and scientists who treat or research those with or at risk for arthritis and rheumatic and musculoskeletal diseases. The annual meeting is the leading forum for you to find the most relevant and cutting-edge rheumatology information. ...
today announces it will be presenting the results from its Phase II trial of LEVI-04 in an oral presentation at the American College of Rheumatology's annual meeting, ACR Convergence 2024, being
ConferenceRheumatologyAmerican College of Rheumatology February 5th 2025 Perceived Stressed Associated With Symptom Burden in People With Fibromyalgia Victoria Johnson October 28th 2024 Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024...
doi:10.3899/jrheum.2024-0335antineutrophil cytoplasmic antibody–associated vasculitisChurg-Strauss syndromeclassificationgranulomatosis with polyangiitisinterstitial lung diseasemicroscopic polyangiitisObjective This study aimed to compare the 2022 American College of Rheumatology (ACR)/European Alliance of Associations...
Chemomab Therapeutics Ltd. reported on its poster presentation at the American College of Rheumatology Convergence 2023 conference.